Inventor
NASH ANDREW DONALD
AU17 patents
⚠️ This page may combine multiple inventors who share the name “NASH ANDREW DONALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CSL LTD
5 patentsUS9777062B2Oct 3, 2017
High affinity antibody antagonists of interleukin-13 receptor alpha 1
CSL LTD1 citations62
US9371388B2Jun 21, 2016
High affinity antibody antagonists of interleukin-13 receptor alpha 1
CSL LTD2 citations62
US12071484B2Aug 27, 2024
Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein
CSL LTD0 citations56
US10106617B2Oct 23, 2018
High affinity antibody antagonists of interleukin-13 receptor alpha 1
CSL LTD0 citations51
US9376682B2Jun 28, 2016
Method of treating pulmonary disease by administering an antibody to G-CSF
CSL LTD0 citations44
NASH ANDREW DONALD
4 patentsUS9193793B2Nov 24, 2015
Antibodies against G-CSFR and uses thereof
NASH ANDREW DONALD6 citations77
US8568722B2Oct 29, 2013
High affinity antibody antagonists of interleukin-13 receptor alpha 1
NASH ANDREW DONALD2 citations60
US8207304B2Jun 26, 2012
Antibody antagonists of interleukin-13 receptor α1
NASH ANDREW DONALD2 citations60
US8613925B2Dec 24, 2013
Anti-IL-13Rα1 antibodies and their uses thereof
NASH ANDREW DONALD1 citations50